The purpose of this study was to compare the pharmacokinetic and bioavailability profile
(rate and amount of absorption into the bloodstream) of a test formulation of ivermectin
solution 1 mg/ml with a marketed reference formulation of ivermectin 3 mg tablets when taken
after an overnight fast .The study is designed in accordance with the EU Note for Guidance on
the Investigation of Bioavailability and Bioequivalence 2001.
Phase:
Phase 1
Details
Lead Sponsor:
Johnson & Johnson Consumer and Personal Products Worldwide